首页 > 最新文献

Cornea最新文献

英文 中文
Quantum Molecular Resonance Electrotherapy for the Treatment of Pediatric Ocular Rosacea. 量子分子共振电疗法治疗小儿酒渣鼻。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-02-01 Epub Date: 2024-07-05 DOI: 10.1097/ICO.0000000000003627
Leena Surapaneni, Ioannis Giachos, Sotiria Palioura

Purpose: The purpose of this study was to report the outcomes of quantum molecular resonance (QMR) electrotherapy in the management of refractory pediatric ocular rosacea.

Methods: This is a retrospective case series on 3 female pediatric patients (ages 12, 15, 14 years) with ocular rosacea. Two patients presented with corneal stromal neovascularization and punctate epithelial erosions while 1 patient presented with corneal scarring and paracentral stromal thinning. After failing conservative management, the patients were treated with 4 consecutive QMR electrotherapy sessions with the intensity set at 5 corresponding on average to a power of 12 W, with 60 V voltage and 200 mA current. Informed consent was obtained for off-label use. Patients were assessed for changes in vision, foreign body sensation, tearing, photophobia, and redness at each visit to determine symptomatic improvement. Outcome measures include best-corrected visual acuity, use of supplemental therapies (eg topical steroids) for symptom relief, extent of corneal neovascularization via serial slitlamp photography, and corneal scar remodeling via high resolution anterior segment optical coherence tomography.

Results: Two of the 3 patients experienced improvement in visual acuity after QMR electrotherapy. Corneal neovascularization and scarring regressed significantly in all 3 patients. Two months post-QMR electrotherapy, corneal remodeling was evident on optical coherence tomography in 2 patients. All 3 patients were able to discontinue topical immunosuppressants and remain symptom-free at 1.5 years of follow-up.

Conclusions: QMR electrotherapy is a promising alternative in the treatment of refractory ocular rosacea in childhood and puberty, and it may potentiate corneal remodeling.

目的:本研究旨在报告量子分子共振(QMR)电疗法在治疗难治性小儿酒渣鼻中的效果:这是一项回顾性病例系列研究,涉及 3 名患有酒渣鼻的女性儿童患者(年龄分别为 12、15 和 14 岁)。两名患者出现角膜基质新生血管和点状上皮糜烂,一名患者出现角膜瘢痕和中央旁基质变薄。在保守治疗失败后,患者接受了连续 4 次 QMR 电疗,强度设定为 5,平均功率为 12 W,电压为 60 V,电流为 200 mA。标示外使用已获得知情同意。每次就诊时都会评估患者的视力变化、异物感、流泪、畏光和发红情况,以确定症状是否得到改善。结果指标包括最佳矫正视力、为缓解症状而使用的辅助疗法(如外用类固醇)、通过连续裂隙灯摄影观察角膜新生血管的程度,以及通过高分辨率前段光学相干断层扫描(OCT)观察角膜瘢痕重塑情况:结果:3 名患者中有 2 名在接受 QMR 电疗后视力有所改善。所有 3 名患者的角膜新生血管和瘢痕都明显消退。QMR 电疗两个月后,2 名患者的光学相干断层扫描显示角膜重塑明显。所有 3 名患者都能停用局部免疫抑制剂,并在 1.5 年的随访中保持无症状:结论:QMR 电疗是治疗儿童和青春期难治性酒渣鼻的一种有前途的替代疗法,它可能会促进角膜重塑。
{"title":"Quantum Molecular Resonance Electrotherapy for the Treatment of Pediatric Ocular Rosacea.","authors":"Leena Surapaneni, Ioannis Giachos, Sotiria Palioura","doi":"10.1097/ICO.0000000000003627","DOIUrl":"10.1097/ICO.0000000000003627","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to report the outcomes of quantum molecular resonance (QMR) electrotherapy in the management of refractory pediatric ocular rosacea.</p><p><strong>Methods: </strong>This is a retrospective case series on 3 female pediatric patients (ages 12, 15, 14 years) with ocular rosacea. Two patients presented with corneal stromal neovascularization and punctate epithelial erosions while 1 patient presented with corneal scarring and paracentral stromal thinning. After failing conservative management, the patients were treated with 4 consecutive QMR electrotherapy sessions with the intensity set at 5 corresponding on average to a power of 12 W, with 60 V voltage and 200 mA current. Informed consent was obtained for off-label use. Patients were assessed for changes in vision, foreign body sensation, tearing, photophobia, and redness at each visit to determine symptomatic improvement. Outcome measures include best-corrected visual acuity, use of supplemental therapies (eg topical steroids) for symptom relief, extent of corneal neovascularization via serial slitlamp photography, and corneal scar remodeling via high resolution anterior segment optical coherence tomography.</p><p><strong>Results: </strong>Two of the 3 patients experienced improvement in visual acuity after QMR electrotherapy. Corneal neovascularization and scarring regressed significantly in all 3 patients. Two months post-QMR electrotherapy, corneal remodeling was evident on optical coherence tomography in 2 patients. All 3 patients were able to discontinue topical immunosuppressants and remain symptom-free at 1.5 years of follow-up.</p><p><strong>Conclusions: </strong>QMR electrotherapy is a promising alternative in the treatment of refractory ocular rosacea in childhood and puberty, and it may potentiate corneal remodeling.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"157-162"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141533910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Success in Descemet Membrane Endothelial Keratoplasty Using Machine Learning. 利用机器学习预测脱落膜内皮角膜移植手术的成功率
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-02-01 Epub Date: 2024-06-20 DOI: 10.1097/ICO.0000000000003599
Emine Esra Karaca, Ayça Bulut Ustael, Ali Seydi Keçeli, Aydin Kaya, Alaettin Uçan, Ozlem Evren Kemer

Purpose: This study aimed to predict early graft failure (GF) in patients who underwent Descemet membrane endothelial keratoplasty based on donor characteristics.

Methods: Several machine learning methods were trained to predict GF automatically. To predict GF, the following variables were obtained: donor age, sex, systemic diseases, medications, duration of stay in the intensive care unit, death-to-preservation time (DPT), endothelial cell density of the cornea, tightness of Descemet membrane roll during surgery, anterior chamber tamponade, tamponade used for rebubbling, and preoperative best corrected visual acuity. Five classification methods were experimented with the study data set: random forest, support vector machine, k-nearest neighbor, RUSBoosted tree, and neural networks. In holdout validation, 75% of the data were used in training and the remaining 25% used in testing. The predictive accuracy, sensitivity, specificity, f-score, and area under the receiver operating characteristic curve of the methods were evaluated.

Results: The highest classification accuracy achieved during the experiments was 96%. The precision, recall, and f1-score values were 0.95, 0.81, and 0.90, respectively. Feature importance was also computed using analysis of variance. The model revealed that GF risk was related to DPT and the intensive care unit duration ( P < 0.05). No significant relationship was found between donor age, endothelial cell density, systemic diseases and medications, graft roll, tamponades, and GF risk.

Conclusions: This study shows a strong relationship between increased intensive care duration, DPT, and GF. Experimental results demonstrate that machine learning methods may effectively predict GF automatically.

目的:本研究旨在根据供体特征预测接受 Descemet 膜内皮角膜移植术(Descemet membrane endothelial keratoplasty)患者的早期移植失败(GF):方法:训练了几种机器学习方法来自动预测 GF。为了预测 GF,我们获取了以下变量:供体年龄、性别、全身性疾病、用药情况、重症监护室住院时间、死亡至保存时间(DPT)、角膜内皮细胞密度、手术过程中 Descemet 膜卷的松紧度、前房填塞物、用于回泡的填塞物和术前最佳矫正视力。研究数据集尝试了五种分类方法:随机森林、支持向量机、k-近邻、RUSBoosted 树和神经网络。在保留验证中,75% 的数据用于训练,其余 25% 用于测试。对这些方法的预测准确性、灵敏度、特异性、f-分数和接收者工作特征曲线下面积进行了评估:实验中达到的最高分类准确率为 96%。精确度、召回率和 f1 分数分别为 0.95、0.81 和 0.90。此外,还利用方差分析计算了特征重要性。模型显示,GF 风险与 DPT 和重症监护室持续时间有关(P < 0.05)。供体年龄、内皮细胞密度、全身性疾病和药物、移植物滚动、填塞和GF风险之间没有发现明显的关系:本研究表明,重症监护时间延长、DPT 和 GF 之间存在密切关系。实验结果表明,机器学习方法可以有效地自动预测 GF。
{"title":"Predicting Success in Descemet Membrane Endothelial Keratoplasty Using Machine Learning.","authors":"Emine Esra Karaca, Ayça Bulut Ustael, Ali Seydi Keçeli, Aydin Kaya, Alaettin Uçan, Ozlem Evren Kemer","doi":"10.1097/ICO.0000000000003599","DOIUrl":"10.1097/ICO.0000000000003599","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to predict early graft failure (GF) in patients who underwent Descemet membrane endothelial keratoplasty based on donor characteristics.</p><p><strong>Methods: </strong>Several machine learning methods were trained to predict GF automatically. To predict GF, the following variables were obtained: donor age, sex, systemic diseases, medications, duration of stay in the intensive care unit, death-to-preservation time (DPT), endothelial cell density of the cornea, tightness of Descemet membrane roll during surgery, anterior chamber tamponade, tamponade used for rebubbling, and preoperative best corrected visual acuity. Five classification methods were experimented with the study data set: random forest, support vector machine, k-nearest neighbor, RUSBoosted tree, and neural networks. In holdout validation, 75% of the data were used in training and the remaining 25% used in testing. The predictive accuracy, sensitivity, specificity, f-score, and area under the receiver operating characteristic curve of the methods were evaluated.</p><p><strong>Results: </strong>The highest classification accuracy achieved during the experiments was 96%. The precision, recall, and f1-score values were 0.95, 0.81, and 0.90, respectively. Feature importance was also computed using analysis of variance. The model revealed that GF risk was related to DPT and the intensive care unit duration ( P < 0.05). No significant relationship was found between donor age, endothelial cell density, systemic diseases and medications, graft roll, tamponades, and GF risk.</p><p><strong>Conclusions: </strong>This study shows a strong relationship between increased intensive care duration, DPT, and GF. Experimental results demonstrate that machine learning methods may effectively predict GF automatically.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"189-195"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141445848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visualization of Keratopathy Associated With the Antibody-Drug Conjugate Belantamab Mafodotin Using Infrared Imaging in Patients With Multiple Myeloma. 利用红外成像观察多发性骨髓瘤患者中与抗体药物结合剂贝兰他单抗马福多汀相关的角膜病变
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-02-01 Epub Date: 2024-06-18 DOI: 10.1097/ICO.0000000000003596
Vivian Gallin, Bernhard Nölle, Natalie Schub, Johann Roider

Purpose: The treatment of patients with relapsed/refractory multiple myeloma (RRMM) with the antibody-drug conjugate belantamab mafodotin is affected by ocular adverse effects, most frequently keratopathy with corneal microcyst-like epithelial changes (MECs). To assess ocular side effects, the Keratopathy and Visual Acuity (KVA) scale, based on the extent of keratopathy subjectively graded on slit-lamp examination and the change in best corrected visual acuity from baseline, was created. Advanced corneal imaging techniques have been explored to further characterize MECs and identify objective imaging biomarkers. We examined whether infrared reflectance imaging of the anterior segment (AS-IR) could contribute to the assessment, monitoring, and documentation of corneal toxicity in patients treated with belantamab mafodotin.

Methods: In addition to the KVA examination, AS-IR imaging was performed. AS-IR images were evaluated for presence of visible hyporeflective lesions and their spatial and temporal distribution between visits and compared with keratopathy identified on slit-lamp examination. To standardize the assessment, a scoring system for lesions on AS-IR was implemented for additional analysis.

Results: Nine patients undergoing treatment with belantamab mafodotin for up to 9 months were examined. All patients exhibited hyporeflective lesions on AS-IR imaging, indicative of corneal toxicity corresponding to MECs observed on slit-lamp examination. AS-IR lesions showed early occurrence, variable quantity and size, and distinct distribution patterns, correlating with clinical findings during treatment.

Conclusions: As shown for belantamab mafodotin, AS-IR imaging represents a fast, noninvasive, supplemental method for documentation, monitoring, and assessment of corneal adverse effects during treatment with antibody-drug conjugates, which may enable more standardized analyses.

目的:对复发性/难治性多发性骨髓瘤(RRMM)患者使用抗体药物共轭物贝仑单抗马福多汀进行治疗时会出现眼部不良反应,其中最常见的是角膜病变和角膜微囊样上皮变化(MECs)。为了评估眼部副作用,根据裂隙灯检查中主观分级的角膜病变程度和最佳矫正视力与基线相比的变化,制定了 "角膜病变和视力(KVA)量表"。为了进一步描述 MECs 的特征并确定客观的成像生物标志物,人们对先进的角膜成像技术进行了探索。我们研究了前段红外反射成像(AS-IR)是否有助于评估、监测和记录接受贝仑单抗马福多汀治疗的患者的角膜毒性:除 KVA 检查外,还进行了 AS-IR 成像检查。方法:除 KVA 检查外,还进行 AS-IR 成像检查,评估是否存在可见的低反射病变及其在就诊期间的空间和时间分布,并与裂隙灯检查发现的角膜病变进行比较。为了使评估标准化,还采用了 AS-IR 病变评分系统进行补充分析:对接受贝仑单抗-马福多汀治疗长达 9 个月的 9 名患者进行了检查。所有患者在 AS-IR 成像上都显示出低反射性病变,这表明角膜毒性与裂隙灯检查中观察到的 MECs 相对应。AS-IR病变出现早,数量和大小不一,分布模式明显,与治疗期间的临床发现相关:正如贝兰他单抗马福多汀所显示的,AS-IR成像是一种快速、无创、补充性的方法,可用于记录、监测和评估抗体药物共轭物治疗期间的角膜不良反应,从而使分析更加标准化。
{"title":"Visualization of Keratopathy Associated With the Antibody-Drug Conjugate Belantamab Mafodotin Using Infrared Imaging in Patients With Multiple Myeloma.","authors":"Vivian Gallin, Bernhard Nölle, Natalie Schub, Johann Roider","doi":"10.1097/ICO.0000000000003596","DOIUrl":"10.1097/ICO.0000000000003596","url":null,"abstract":"<p><strong>Purpose: </strong>The treatment of patients with relapsed/refractory multiple myeloma (RRMM) with the antibody-drug conjugate belantamab mafodotin is affected by ocular adverse effects, most frequently keratopathy with corneal microcyst-like epithelial changes (MECs). To assess ocular side effects, the Keratopathy and Visual Acuity (KVA) scale, based on the extent of keratopathy subjectively graded on slit-lamp examination and the change in best corrected visual acuity from baseline, was created. Advanced corneal imaging techniques have been explored to further characterize MECs and identify objective imaging biomarkers. We examined whether infrared reflectance imaging of the anterior segment (AS-IR) could contribute to the assessment, monitoring, and documentation of corneal toxicity in patients treated with belantamab mafodotin.</p><p><strong>Methods: </strong>In addition to the KVA examination, AS-IR imaging was performed. AS-IR images were evaluated for presence of visible hyporeflective lesions and their spatial and temporal distribution between visits and compared with keratopathy identified on slit-lamp examination. To standardize the assessment, a scoring system for lesions on AS-IR was implemented for additional analysis.</p><p><strong>Results: </strong>Nine patients undergoing treatment with belantamab mafodotin for up to 9 months were examined. All patients exhibited hyporeflective lesions on AS-IR imaging, indicative of corneal toxicity corresponding to MECs observed on slit-lamp examination. AS-IR lesions showed early occurrence, variable quantity and size, and distinct distribution patterns, correlating with clinical findings during treatment.</p><p><strong>Conclusions: </strong>As shown for belantamab mafodotin, AS-IR imaging represents a fast, noninvasive, supplemental method for documentation, monitoring, and assessment of corneal adverse effects during treatment with antibody-drug conjugates, which may enable more standardized analyses.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"196-202"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11676612/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141431617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of RCI001 as a Therapeutic Candidate in a Primary Sjögren Syndrome Mouse Model. RCI001 作为候选治疗药物在原发性 Sjögren 综合征小鼠模型中的疗效。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-02-01 Epub Date: 2024-12-26 DOI: 10.1097/ICO.0000000000003696
Hyereen Kang, Young-Ho Jung, Jayoon Moon, Jin Suk Ryu, Chang Ho Yoon, Yong Ho Kim, Mee Kum Kim, Dong Hyun Kim

Purpose: The aim of this study was to investigate the efficacy of RCI001 (RCI) in a mouse model of primary Sjögren syndrome.

Methods: Eight 12-week-old NOD.B10-H2b mice were used in this study. All experimental animals were randomly divided into phosphate-buffered saline (PBS) and RCI groups in NOD.B10-H2b mice. The eyes of mice were topically treated with PBS or RCI twice a day for a week. Ocular surface staining (OSS) and tear secretion were compared between before and after treatment. The transcript levels of inflammatory cytokines and nicotinamide adenine dinucleotide phosphate oxidase (NOX) in the conjunctiva and cornea (CC) and lacrimal gland were assayed. In addition, immunofluorescence staining of the conjunctiva was assessed.

Results: The RCI group showed significant clinical improvement in OSS and tear secretion after 1 week of treatment compared with the baseline (both P < 0.001) and showed better improvement in OSS and tear secretion than the PBS group after 1 week of treatment (both P < 0.05). The levels of IL-1β and IL-17 in CC and IL-6 in the lacrimal gland were also significantly reduced in the RCI group compared with the PBS group (each P < 0.05). Transcript levels of NOX2 and NOX4 were also significantly reduced in CC of the RCI group compared with those of the PBS group ( P < 0.05). The RCI group also resulted in lower conjunctival expression of oxidative stress markers (4-hydroxy-2-nonenal, hexanoyl-lysine, and NOX4) than the PBS group.

Conclusions: Topical RCI001 demonstrated excellent therapeutic efficacy in a mouse model of primary Sjögren syndrome by inhibiting inflammation and oxidative stress.

目的:本研究旨在探讨 RCI001(RCI)在原发性斯约恩综合征小鼠模型中的疗效:本研究使用了 8 只 12 周大的 NOD.B10-H2b 小鼠。将所有实验动物随机分为磷酸盐缓冲液(PBS)组和 RCI 组。小鼠的眼睛接受 PBS 或 RCI 局部治疗,每天两次,持续一周。比较治疗前后的眼表染色(OSS)和泪液分泌情况。检测结膜、角膜(CC)和泪腺中炎症细胞因子和烟酰胺腺嘌呤二核苷酸磷酸氧化酶(NOX)的转录水平。此外,还对结膜的免疫荧光染色进行了评估:结果:治疗一周后,RCI 组的 OSS 和泪液分泌量与基线相比有明显的临床改善(均 P < 0.001),且治疗一周后 OSS 和泪液分泌量的改善效果优于 PBS 组(均 P < 0.05)。与 PBS 组相比,RCI 组 CC 中的 IL-1β 和 IL-17 以及泪腺中的 IL-6 水平也显著降低(均 P <0.05)。与 PBS 组相比,RCI 组 CC 中 NOX2 和 NOX4 的转录水平也明显降低(P < 0.05)。与 PBS 组相比,RCI 组结膜氧化应激标记物(4-羟基-2-壬烯醛、己酰赖氨酸和 NOX4)的表达也更低:通过抑制炎症和氧化应激,外用 RCI001 在原发性斯约恩综合征小鼠模型中显示出了卓越的疗效。
{"title":"Efficacy of RCI001 as a Therapeutic Candidate in a Primary Sjögren Syndrome Mouse Model.","authors":"Hyereen Kang, Young-Ho Jung, Jayoon Moon, Jin Suk Ryu, Chang Ho Yoon, Yong Ho Kim, Mee Kum Kim, Dong Hyun Kim","doi":"10.1097/ICO.0000000000003696","DOIUrl":"10.1097/ICO.0000000000003696","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to investigate the efficacy of RCI001 (RCI) in a mouse model of primary Sjögren syndrome.</p><p><strong>Methods: </strong>Eight 12-week-old NOD.B10-H2b mice were used in this study. All experimental animals were randomly divided into phosphate-buffered saline (PBS) and RCI groups in NOD.B10-H2b mice. The eyes of mice were topically treated with PBS or RCI twice a day for a week. Ocular surface staining (OSS) and tear secretion were compared between before and after treatment. The transcript levels of inflammatory cytokines and nicotinamide adenine dinucleotide phosphate oxidase (NOX) in the conjunctiva and cornea (CC) and lacrimal gland were assayed. In addition, immunofluorescence staining of the conjunctiva was assessed.</p><p><strong>Results: </strong>The RCI group showed significant clinical improvement in OSS and tear secretion after 1 week of treatment compared with the baseline (both P < 0.001) and showed better improvement in OSS and tear secretion than the PBS group after 1 week of treatment (both P < 0.05). The levels of IL-1β and IL-17 in CC and IL-6 in the lacrimal gland were also significantly reduced in the RCI group compared with the PBS group (each P < 0.05). Transcript levels of NOX2 and NOX4 were also significantly reduced in CC of the RCI group compared with those of the PBS group ( P < 0.05). The RCI group also resulted in lower conjunctival expression of oxidative stress markers (4-hydroxy-2-nonenal, hexanoyl-lysine, and NOX4) than the PBS group.</p><p><strong>Conclusions: </strong>Topical RCI001 demonstrated excellent therapeutic efficacy in a mouse model of primary Sjögren syndrome by inhibiting inflammation and oxidative stress.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"226-233"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11676593/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142281592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Pathophysiology of Keratoconus. 角膜炎的病理生理学。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-02-01 Epub Date: 2024-05-30 DOI: 10.1097/ICO.0000000000003585
Rita Vought, Steven A Greenstein, John Gelles, Peter S Hersh

Purpose: Keratoconus is a progressive disease characterized by changes in corneal shape, resulting in loss of visual function. There remains a lack of comprehensive understanding regarding its underlying pathophysiology. This review aims to bridge this gap by exploring structural failures and inflammatory processes involved in the etiology and progression of keratoconus.

Methods: A literature review was conducted using PubMed and Google Scholar databases, screening for articles published in English using the keyword combinations of "keratoconus" with "pathophysiology," "pathology," "metabolism," "inflammatory," "oxidative stress," "cytokines," "enzymes," "collagen," and "cornea." Articles published between January 1, 1970, and June 1, 2023, were queried and reviewed, with greater emphasis placed on more recent data. Fifty-six relevant studies were examined to develop a thorough review of the pathophysiological mechanisms at play in keratoconus.

Results: Biomechanical structural failures in the cornea seem to be the primary militating factors in keratoconus etiology and progression. These include disruptions in the arrangement in the collagen lamellae, a decrease in collagen levels, a decrease in natural collagen crosslinking, and changes in lysosomal enzyme activity. Immunologic changes have also been identified in keratoconus, challenging the traditional view of the condition as noninflammatory. Elevated levels of proinflammatory cytokines like IL-1b, IL-6, IL-17, and TNF-α have been observed, along with increased apoptosis of keratocytes. Increased oxidative stress leads to the activation of collagenase and gelatinase enzymes.

Conclusions: Keratoconus is a complex condition influenced by both structural defects and inflammatory processes. Understanding these mechanisms can inform clinical management and potentially lead to more effective treatments.

目的:角膜炎是一种渐进性疾病,其特点是角膜形状发生变化,导致视觉功能丧失。人们对其潜在的病理生理学仍缺乏全面的了解。本综述旨在通过探讨角膜炎的病因和进展过程中涉及的结构性故障和炎症过程来弥补这一不足:我们使用 PubMed 和 Google Scholar 数据库进行了文献综述,使用 "角膜病 "与 "病理生理学"、"病理学"、"新陈代谢"、"炎症"、"氧化应激"、"细胞因子"、"酶"、"胶原蛋白 "和 "角膜 "的关键词组合筛选英文发表的文章。对 1970 年 1 月 1 日至 2023 年 6 月 1 日期间发表的文章进行了查询和审查,重点放在较新的数据上。共研究了 56 项相关研究,对角膜病的病理生理机制进行了全面回顾:结果:角膜的生物力学结构故障似乎是角膜炎病因和发展的主要影响因素。这些因素包括胶原层排列紊乱、胶原含量下降、天然胶原交联减少以及溶酶体酶活性的变化。在角膜炎中还发现了免疫学变化,这对将角膜炎视为非炎症性疾病的传统观点提出了挑战。已观察到促炎细胞因子如 IL-1b、IL-6、IL-17 和 TNF-α 水平升高,同时角膜细胞凋亡增加。氧化应激的增加导致胶原酶和明胶酶的活化:结论:角膜炎是一种受结构缺陷和炎症过程影响的复杂疾病。了解这些机制可为临床管理提供依据,并有可能开发出更有效的治疗方法。
{"title":"The Pathophysiology of Keratoconus.","authors":"Rita Vought, Steven A Greenstein, John Gelles, Peter S Hersh","doi":"10.1097/ICO.0000000000003585","DOIUrl":"10.1097/ICO.0000000000003585","url":null,"abstract":"<p><strong>Purpose: </strong>Keratoconus is a progressive disease characterized by changes in corneal shape, resulting in loss of visual function. There remains a lack of comprehensive understanding regarding its underlying pathophysiology. This review aims to bridge this gap by exploring structural failures and inflammatory processes involved in the etiology and progression of keratoconus.</p><p><strong>Methods: </strong>A literature review was conducted using PubMed and Google Scholar databases, screening for articles published in English using the keyword combinations of \"keratoconus\" with \"pathophysiology,\" \"pathology,\" \"metabolism,\" \"inflammatory,\" \"oxidative stress,\" \"cytokines,\" \"enzymes,\" \"collagen,\" and \"cornea.\" Articles published between January 1, 1970, and June 1, 2023, were queried and reviewed, with greater emphasis placed on more recent data. Fifty-six relevant studies were examined to develop a thorough review of the pathophysiological mechanisms at play in keratoconus.</p><p><strong>Results: </strong>Biomechanical structural failures in the cornea seem to be the primary militating factors in keratoconus etiology and progression. These include disruptions in the arrangement in the collagen lamellae, a decrease in collagen levels, a decrease in natural collagen crosslinking, and changes in lysosomal enzyme activity. Immunologic changes have also been identified in keratoconus, challenging the traditional view of the condition as noninflammatory. Elevated levels of proinflammatory cytokines like IL-1b, IL-6, IL-17, and TNF-α have been observed, along with increased apoptosis of keratocytes. Increased oxidative stress leads to the activation of collagenase and gelatinase enzymes.</p><p><strong>Conclusions: </strong>Keratoconus is a complex condition influenced by both structural defects and inflammatory processes. Understanding these mechanisms can inform clinical management and potentially lead to more effective treatments.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"137-143"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Herpesviral Keratitis Following COVID-19 Vaccination: Analysis of NHIS Database in Korea. 接种 COVID-19 疫苗后的疱疹病毒性角膜炎:韩国 NHIS 数据库分析。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-02-01 Epub Date: 2024-05-08 DOI: 10.1097/ICO.0000000000003556
Tae Eun Lee, Sung Hyun Ahn, Cho Yun Jeong, Jong Seung Kim, In Cheon You

Purpose: The purpose of this study was to determine the risk of herpesviral keratitis associated with 4 coronavirus disease 2019 (COVID-19) vaccines approved in South Korea, using large-scale data from the National Health Insurance Service.

Methods: The study included 8,528,254 individuals, with cohorts categorized based on COVID-19 vaccination status. Two investigations were conducted: The first aimed to assess the risk of new-onset herpesviral keratitis while the second study focused on the risk of relapse in individuals with a preexisting diagnosis. Propensity score matching was used for cohort balancing, and various covariates, including vaccine types and comorbidities, were considered. Statistical analyses, including Cox proportional hazard regression, were used to calculate adjusted hazard ratio (aHR) and assess the risk of herpesviral keratitis.

Results: Individuals receiving COVID-19 vaccination exhibited a higher risk of new-onset herpesviral keratitis compared with the unvaccinated control group (aHR 1.43, 95% confidence interval, 1.19-1.73). Both mRNA and non-mRNA vaccines demonstrated an increased risk. Individuals with preexisting herpetic keratitis who received COVID-19 vaccination showed a higher risk of relapse herpesviral keratitis compared with the unvaccinated control group (aHR 1.98, 95% CI, 1.29-3.03). Sensitivity analyses supported the robustness of the results.

Conclusions: This analysis of a large national health insurance database suggests an increased risk of both new-onset and relapse of herpesviral keratitis associated with COVID-19 vaccination in South Korea. While COVID-19 vaccination is crucial for pandemic control, health care providers should be aware of potential herpesvirus reactivation and consider appropriate prophylaxis and treatment for at-risk individuals.

目的:本研究的目的是利用国民健康保险服务的大规模数据,确定与韩国批准的 4 种冠状病毒病 2019(COVID-19)疫苗相关的疱疹病毒性角膜炎风险:研究包括 852.8254 万人,根据 COVID-19 疫苗接种情况进行分组。共进行了两项调查:第一项研究旨在评估新发疱疹病毒性角膜炎的风险,而第二项研究则侧重于已确诊患者的复发风险。研究采用倾向评分匹配法进行队列平衡,并考虑了各种协变量,包括疫苗类型和合并症。统计分析(包括 Cox 比例危险回归)用于计算调整后的危险比(aHR)和评估疱疹病毒性角膜炎的风险:结果:与未接种疫苗的对照组相比,接种COVID-19疫苗的人患新发疱疹病毒性角膜炎的风险更高(aHR为1.43,95%置信区间为1.19-1.73)。mRNA 和非 mRNA 疫苗均显示风险增加。与未接种疫苗的对照组相比,接种 COVID-19 疫苗的原有疱疹性角膜炎患者复发疱疹病毒性角膜炎的风险更高(aHR 1.98,95% 置信区间:1.29-3.03)。敏感性分析证实了结果的稳健性:这项对大型全国医疗保险数据库的分析表明,在韩国接种 COVID-19 疫苗会增加疱疹病毒性角膜炎的新发和复发风险。虽然接种 COVID-19 疫苗对控制大流行至关重要,但医疗服务提供者也应意识到潜在的疱疹病毒再活化,并考虑对高危人群进行适当的预防和治疗。
{"title":"Herpesviral Keratitis Following COVID-19 Vaccination: Analysis of NHIS Database in Korea.","authors":"Tae Eun Lee, Sung Hyun Ahn, Cho Yun Jeong, Jong Seung Kim, In Cheon You","doi":"10.1097/ICO.0000000000003556","DOIUrl":"10.1097/ICO.0000000000003556","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to determine the risk of herpesviral keratitis associated with 4 coronavirus disease 2019 (COVID-19) vaccines approved in South Korea, using large-scale data from the National Health Insurance Service.</p><p><strong>Methods: </strong>The study included 8,528,254 individuals, with cohorts categorized based on COVID-19 vaccination status. Two investigations were conducted: The first aimed to assess the risk of new-onset herpesviral keratitis while the second study focused on the risk of relapse in individuals with a preexisting diagnosis. Propensity score matching was used for cohort balancing, and various covariates, including vaccine types and comorbidities, were considered. Statistical analyses, including Cox proportional hazard regression, were used to calculate adjusted hazard ratio (aHR) and assess the risk of herpesviral keratitis.</p><p><strong>Results: </strong>Individuals receiving COVID-19 vaccination exhibited a higher risk of new-onset herpesviral keratitis compared with the unvaccinated control group (aHR 1.43, 95% confidence interval, 1.19-1.73). Both mRNA and non-mRNA vaccines demonstrated an increased risk. Individuals with preexisting herpetic keratitis who received COVID-19 vaccination showed a higher risk of relapse herpesviral keratitis compared with the unvaccinated control group (aHR 1.98, 95% CI, 1.29-3.03). Sensitivity analyses supported the robustness of the results.</p><p><strong>Conclusions: </strong>This analysis of a large national health insurance database suggests an increased risk of both new-onset and relapse of herpesviral keratitis associated with COVID-19 vaccination in South Korea. While COVID-19 vaccination is crucial for pandemic control, health care providers should be aware of potential herpesvirus reactivation and consider appropriate prophylaxis and treatment for at-risk individuals.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"168-179"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11676602/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140891707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Principal Component Analysis of a Real-World Cohort of Descemet Stripping Automated Endothelial Keratoplasty and Descemet Membrane Endothelial Keratoplasty Cases: Demonstration of a Powerful Data-Mining Technique for Identifying Areas of Research. 对真实世界中的脱丝膜剥离自动内皮角膜移植术和脱丝膜内皮角膜移植术病例群进行主成分分析:展示强大的数据挖掘技术,确定研究领域。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-02-01 Epub Date: 2024-05-29 DOI: 10.1097/ICO.0000000000003584
Jean-Marc Perone, Christophe Goetz, Yinka Zevering, Alexis Derumigny

Purpose: Principal component analysis (PCA) is a descriptive exploratory statistical technique that is widely used in complex fields for data mining. However, it is rarely used in ophthalmology. We explored its research potential with a large series of eyes that underwent 3 keratoplasty techniques: Descemet membrane endothelial keratoplasty (DMEK), conventional Descemet stripping automated endothelial keratoplasty (ConDSAEK), or ultrathin-DSAEK (UT-DSAEK).

Methods: All consecutive DMEK/DSAEK cases conducted in 2016 to 2022 that had ≥24 months of follow-up were included. ConDSAEK and UT-DSAEK were defined as preoperative central graft thickness ≥130 and <130 μm, respectively. Seventy-six patient, disease, surgical practice, and temporal outcome variables were subjected to PCA, including preoperative anterior keratometry, the use of sulfur hexafluoride gas (SF6) versus air for primary tamponade, and postoperative best corrected visual acuity and endothelial cell density. Associations of interest that were revealed by PCA were assessed with the Welch t test or Pearson test.

Results: A total of 331 eyes were treated with DMEK (n = 165), ConDSAEK (n = 95), or UT-DSAEK (n = 71). PCA showed that ConDSAEK and UT-DSAEK clustered closely, including regarding postoperative best corrected visual acuity, and were clearly distinct from DMEK. PCA and follow-up univariate analyses suggested that in DMEK, 1) flatter preoperative anterior keratometry (average, K1, and K2) associated with more rebubbling ( P = 0.004-0.089) and graft detachment ( P = 0.007-0.022); 2) graft marking did not affect postoperative endothelial cell density; and 3) lower postoperative endothelial cell density associated with SF6 use (all P > 0.001) and longer surgery ( P = 0.005-0.091). All associations are currently under additional investigation in our hospital.

Conclusions: PCA is a powerful technique that can rapidly reveal clinically relevant associations in complex ophthalmological datasets.

目的:主成分分析(PCA)是一种描述性探索统计技术,广泛应用于复杂领域的数据挖掘。但在眼科领域却很少使用。我们通过大量接受过三种角膜移植技术的眼睛来探索其研究潜力:方法:纳入2016年至2022年进行的所有随访时间≥24个月的连续DMEK/DSAEK病例。ConDSAEK和UT-DSAEK的定义是术前中央移植物厚度≥130和结果:共有 331 只眼睛接受了 DMEK(n = 165)、ConDSAEK(n = 95)或 UT-DSAEK (n = 71)治疗。PCA 显示,ConDSAEK 和 UT-DSAEK 聚类紧密,包括术后最佳矫正视力,与 DMEK 有明显区别。PCA 和随访单变量分析表明,在 DMEK 中,1)术前较平坦的前角膜度数(平均值、K1 和 K2)与较多的反泡(P = 0.004-0.089)和移植物脱离(P = 0.007-0.022);2)移植物标记不影响术后 ECD;3)术后内皮细胞密度较低与使用 SF6(所有 P > 0.001)和手术时间较长(P = 0.005-0.091)有关。目前,我院正在对所有关联进行进一步调查:PCA是一种强大的技术,能在复杂的眼科数据集中快速揭示与临床相关的关联。
{"title":"Principal Component Analysis of a Real-World Cohort of Descemet Stripping Automated Endothelial Keratoplasty and Descemet Membrane Endothelial Keratoplasty Cases: Demonstration of a Powerful Data-Mining Technique for Identifying Areas of Research.","authors":"Jean-Marc Perone, Christophe Goetz, Yinka Zevering, Alexis Derumigny","doi":"10.1097/ICO.0000000000003584","DOIUrl":"10.1097/ICO.0000000000003584","url":null,"abstract":"<p><strong>Purpose: </strong>Principal component analysis (PCA) is a descriptive exploratory statistical technique that is widely used in complex fields for data mining. However, it is rarely used in ophthalmology. We explored its research potential with a large series of eyes that underwent 3 keratoplasty techniques: Descemet membrane endothelial keratoplasty (DMEK), conventional Descemet stripping automated endothelial keratoplasty (ConDSAEK), or ultrathin-DSAEK (UT-DSAEK).</p><p><strong>Methods: </strong>All consecutive DMEK/DSAEK cases conducted in 2016 to 2022 that had ≥24 months of follow-up were included. ConDSAEK and UT-DSAEK were defined as preoperative central graft thickness ≥130 and <130 μm, respectively. Seventy-six patient, disease, surgical practice, and temporal outcome variables were subjected to PCA, including preoperative anterior keratometry, the use of sulfur hexafluoride gas (SF6) versus air for primary tamponade, and postoperative best corrected visual acuity and endothelial cell density. Associations of interest that were revealed by PCA were assessed with the Welch t test or Pearson test.</p><p><strong>Results: </strong>A total of 331 eyes were treated with DMEK (n = 165), ConDSAEK (n = 95), or UT-DSAEK (n = 71). PCA showed that ConDSAEK and UT-DSAEK clustered closely, including regarding postoperative best corrected visual acuity, and were clearly distinct from DMEK. PCA and follow-up univariate analyses suggested that in DMEK, 1) flatter preoperative anterior keratometry (average, K1, and K2) associated with more rebubbling ( P = 0.004-0.089) and graft detachment ( P = 0.007-0.022); 2) graft marking did not affect postoperative endothelial cell density; and 3) lower postoperative endothelial cell density associated with SF6 use (all P > 0.001) and longer surgery ( P = 0.005-0.091). All associations are currently under additional investigation in our hospital.</p><p><strong>Conclusions: </strong>PCA is a powerful technique that can rapidly reveal clinically relevant associations in complex ophthalmological datasets.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"209-220"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Femtosecond Laser-Assisted Autologous Glueless Simple Limbal Epithelial Transplantation in Unilateral Limbal Stem Cell Deficiency: 12-Month Outcome of the First Clinical Cases. 飞秒激光辅助自体无胶单纯瓣膜上皮移植治疗单侧瓣膜干细胞缺乏症:首例临床病例的 12 个月疗效。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-02-01 Epub Date: 2024-08-27 DOI: 10.1097/ICO.0000000000003688
Boris Malyugin, Kalinnikova Svetlana, Muller Fabian, Bernau Werner, Knyazer Boris, Gerasimov Maksim

Purpose: Surgical treatment of unilateral limbal stem cell deficiency (LSCD) is based on limbal stem cell transplantation. Glueless simple limbal epithelial transplantation (G-SLET) technique implements several limbal micrografts harvested from the healthy eye of the same patient into the peripheral corneal tunnels without the use of fibrin glue and human amniotic membrane.

Methods: A novel customized algorithm and software for a low-energy femtosecond laser (FSL) were developed and tested using 5 pairs of isolated porcine eyes. FSL-assisted G-SLET modification was assessed in 3 clinical cases of unilateral LSCD caused by chemical burns. Corneal epithelization efficacy, best-corrected visual acuity, corneal epithelial mapping, central corneal thickness, and impression cytology with immunohistochemical examination were evaluated. All patients were followed up for 12 months postoperatively.

Results: The FSL set for 100% energy and the pattern of 8 nonpenetrating vertical cuts with oblique tunnel portions having variable incision depths and diameter of 8.5 mm and higher were selected for further clinical evaluation. Clinically, stable corneal epithelialization was achieved 2 to 3 weeks after intervention. At the 6-month follow-up, all patients had a healthy corneal epithelium with limbal micrografts visible inside the corneal tunnels. Best-corrected visual acuity markedly improved in 2 cases, but not in the third case with severe corneal stromal scarring. In addition, all patients noted a full-scale reduction in subjective complaints and substantial improvement in their quality of life.

Conclusions: The FSL-assisted G-SLET is a new technique for autologous limbal stem cell transplantation in patients with unilateral LSCD. It allows the standardization of corneal tunnel localization and dimensions, thereby increasing the safety of the surgical procedure.

目的:单侧角膜缘干细胞缺乏症(LSCD)的手术治疗以角膜缘干细胞移植为基础。无胶简单角膜缘上皮移植(G-SLET)技术无需使用纤维蛋白胶和人羊膜,就能将从同一患者健康眼部采集的多个角膜缘微小移植体植入周边角膜隧道:方法:为低能量飞秒激光(FSL)开发了一种新的定制算法和软件,并用5对离体猪眼进行了测试。在 3 例因化学烧伤引起的单侧 LSCD 临床病例中,对飞秒激光辅助 G-SLET 修饰进行了评估。对角膜上皮化效果、最佳矫正视力、角膜上皮图、角膜中央厚度和印模细胞学与免疫组化检查进行了评估。所有患者术后随访 12 个月:我们选择了FSL设置为100%能量和8个非穿透性垂直切口模式,以及切口深度和直径在8.5毫米及以上的斜隧道切口。临床上,干预后 2 到 3 周,角膜上皮化趋于稳定。在 6 个月的随访中,所有患者的角膜上皮都很健康,角膜隧道内可见角膜缘微移植。其中两名患者的最佳矫正视力明显提高,但角膜基质瘢痕严重的第三名患者的最佳矫正视力没有提高。此外,所有患者的主观不适症状都得到了全面缓解,生活质量大幅提高:结论:FSL辅助G-SLET是一种用于单侧LSCD患者自体角膜缘干细胞移植的新技术。结论:FSL辅助G-SLET是单侧LSCD患者进行自体角膜缘干细胞移植的新技术,可实现角膜隧道定位和尺寸的标准化,从而提高手术的安全性。
{"title":"Femtosecond Laser-Assisted Autologous Glueless Simple Limbal Epithelial Transplantation in Unilateral Limbal Stem Cell Deficiency: 12-Month Outcome of the First Clinical Cases.","authors":"Boris Malyugin, Kalinnikova Svetlana, Muller Fabian, Bernau Werner, Knyazer Boris, Gerasimov Maksim","doi":"10.1097/ICO.0000000000003688","DOIUrl":"10.1097/ICO.0000000000003688","url":null,"abstract":"<p><strong>Purpose: </strong>Surgical treatment of unilateral limbal stem cell deficiency (LSCD) is based on limbal stem cell transplantation. Glueless simple limbal epithelial transplantation (G-SLET) technique implements several limbal micrografts harvested from the healthy eye of the same patient into the peripheral corneal tunnels without the use of fibrin glue and human amniotic membrane.</p><p><strong>Methods: </strong>A novel customized algorithm and software for a low-energy femtosecond laser (FSL) were developed and tested using 5 pairs of isolated porcine eyes. FSL-assisted G-SLET modification was assessed in 3 clinical cases of unilateral LSCD caused by chemical burns. Corneal epithelization efficacy, best-corrected visual acuity, corneal epithelial mapping, central corneal thickness, and impression cytology with immunohistochemical examination were evaluated. All patients were followed up for 12 months postoperatively.</p><p><strong>Results: </strong>The FSL set for 100% energy and the pattern of 8 nonpenetrating vertical cuts with oblique tunnel portions having variable incision depths and diameter of 8.5 mm and higher were selected for further clinical evaluation. Clinically, stable corneal epithelialization was achieved 2 to 3 weeks after intervention. At the 6-month follow-up, all patients had a healthy corneal epithelium with limbal micrografts visible inside the corneal tunnels. Best-corrected visual acuity markedly improved in 2 cases, but not in the third case with severe corneal stromal scarring. In addition, all patients noted a full-scale reduction in subjective complaints and substantial improvement in their quality of life.</p><p><strong>Conclusions: </strong>The FSL-assisted G-SLET is a new technique for autologous limbal stem cell transplantation in patients with unilateral LSCD. It allows the standardization of corneal tunnel localization and dimensions, thereby increasing the safety of the surgical procedure.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"262-270"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142085934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Posterior Lamellar Augmentation With Auricular Cartilage Grafting for Severe Cicatricial Entropion Correction in Cicatricial Ocular Surface Disease.
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-31 DOI: 10.1097/ICO.0000000000003821
Obaidur Rehman, Shirali Gokharu, Virender Sangwan, Sima Das

Purpose: Description of clinical profile, surgical technique, and outcomes in patients having severe entropion secondary to cicatricial ocular surface disorders, who underwent entropion repair and posterior lamellar augmentation using auricular cartilage graft.

Methods: A retrospective review of electronic medical records was performed over a 4-year period (August 2019-August 2023) to identify cases with entropion and cicatrizing ocular surface disorders that had undergone entropion repair with auricular cartilage grafting.

Results: Seventeen eyelids of 15 patients were included. The average age of the study population was 33.17 ± 16.8 years, with an almost equal male to female ratio (8 male, 7 females). Lower eyelid was more commonly involved (n = 11, 64.7%) than the upper eyelid (n = 6). Steven-Johnson syndrome (n = 11, 64.7%) was the most frequent etiology. Two patients (13.3%) underwent bilateral surgical repair, whereas in 5 eyelids (29.4%), the procedure was combined with lid margin mucous membrane grafting at the same sitting. Cartilage graft was harvested through posterior auricular approach in all cases. Postoperatively, entropion correction was achieved in 16 eyelids (94.1%), and postoperative improvement in ocular surface scoring was noted in 11 eyelids (64.7%). Improvement in visual acuity postoperatively was noted in 52.9% eyes. Over an average follow-up of 16.64 months, 1 eyelid (5.8%) required additional everting sutures and 1 eyelid (5.8%) needed trimming of the graft.

Conclusions: Cartilage graft-aided entropion surgery is a viable and satisfactory management option in severe cicatricial entropion in ocular surface disorders and can be combined with lid margin mucous membrane grafting for simultaneous correction of lid margin keratinization. Auricular cartilage is a versatile graft with easy harvesting and minimal donor-site morbidity.

目的:描述继发于卡他性眼表疾病的严重内翻患者的临床概况、手术技术和结果,这些患者接受了内翻修复术和使用耳廓软骨移植的后板层隆起术:对4年间(2019年8月至2023年8月)的电子病历进行回顾性审查,以确定接受了耳廓软骨移植眼睑内翻修复术的眼睑内翻和卡他性眼表疾病病例:共纳入 15 名患者的 17 个眼睑。研究对象的平均年龄为(33.17 ± 16.8)岁,男女比例几乎相等(8 男 7 女)。下眼睑(11 例,64.7%)比上眼睑(6 例)更常见。史蒂芬-约翰逊综合征(11 例,64.7%)是最常见的病因。两名患者(13.3%)接受了双侧手术修复,5 名患者(29.4%)在同一部位接受了睑缘粘膜移植手术。所有病例均通过耳后入路采集软骨。术后,16 个眼睑(94.1%)的内翻得到矫正,11 个眼睑(64.7%)的眼表评分得到改善。52.9%的患者术后视力得到改善。在平均 16.64 个月的随访中,1 个眼睑(5.8%)需要额外的外翻缝合,1 个眼睑(5.8%)需要修剪移植物:软骨移植辅助眼睑内翻手术是眼表疾病中严重卡他性眼睑内翻的一种可行且令人满意的治疗方法,可与睑缘粘膜移植术相结合,同时矫正睑缘角化。耳廓软骨是一种多功能移植物,易于采集,供体部位发病率极低。
{"title":"Posterior Lamellar Augmentation With Auricular Cartilage Grafting for Severe Cicatricial Entropion Correction in Cicatricial Ocular Surface Disease.","authors":"Obaidur Rehman, Shirali Gokharu, Virender Sangwan, Sima Das","doi":"10.1097/ICO.0000000000003821","DOIUrl":"https://doi.org/10.1097/ICO.0000000000003821","url":null,"abstract":"<p><strong>Purpose: </strong>Description of clinical profile, surgical technique, and outcomes in patients having severe entropion secondary to cicatricial ocular surface disorders, who underwent entropion repair and posterior lamellar augmentation using auricular cartilage graft.</p><p><strong>Methods: </strong>A retrospective review of electronic medical records was performed over a 4-year period (August 2019-August 2023) to identify cases with entropion and cicatrizing ocular surface disorders that had undergone entropion repair with auricular cartilage grafting.</p><p><strong>Results: </strong>Seventeen eyelids of 15 patients were included. The average age of the study population was 33.17 ± 16.8 years, with an almost equal male to female ratio (8 male, 7 females). Lower eyelid was more commonly involved (n = 11, 64.7%) than the upper eyelid (n = 6). Steven-Johnson syndrome (n = 11, 64.7%) was the most frequent etiology. Two patients (13.3%) underwent bilateral surgical repair, whereas in 5 eyelids (29.4%), the procedure was combined with lid margin mucous membrane grafting at the same sitting. Cartilage graft was harvested through posterior auricular approach in all cases. Postoperatively, entropion correction was achieved in 16 eyelids (94.1%), and postoperative improvement in ocular surface scoring was noted in 11 eyelids (64.7%). Improvement in visual acuity postoperatively was noted in 52.9% eyes. Over an average follow-up of 16.64 months, 1 eyelid (5.8%) required additional everting sutures and 1 eyelid (5.8%) needed trimming of the graft.</p><p><strong>Conclusions: </strong>Cartilage graft-aided entropion surgery is a viable and satisfactory management option in severe cicatricial entropion in ocular surface disorders and can be combined with lid margin mucous membrane grafting for simultaneous correction of lid margin keratinization. Auricular cartilage is a versatile graft with easy harvesting and minimal donor-site morbidity.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143070754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intermediate-Term Outcomes and Complications of Ahmed Glaucoma Valve in Type 1 Keratoprostheses.
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-29 DOI: 10.1097/ICO.0000000000003819
Gowri Pratinya Kolipaka, Ramyashri Sastry, Naveen Nukala, Swapna S Shanbhag, Sirisha Senthil

Purpose: To evaluate intermediate-term outcomes and complications associated with Ahmed glaucoma valve (AGV) implantation in eyes with type 1 keratoprosthesis (KPro).

Methods: We retrospectively reviewed records of 43 eyes of 43 Indian patients with type 1 KPro and AGV from 2009 to 2021 with a minimum of 6-months of follow-up. Five eyes that had AGV before KPro were excluded, leaving 38 eyes for analysis. Primary outcome measure was postoperative complications. Secondary outcome measure was stability of glaucoma, assessed by Humphrey visual fields, intraocular pressure, and best-corrected visual acuity (BCVA). Sight-threatening complications, implant removal, or repeat glaucoma surgery was considered failure.

Results: Median age (interquartile range) at AGV implantation was 36.5 (23-49) years, with median post-AGV follow-up of 30.5 (6.5-53) months. Preoperative logarithm of minimal angle of resolution median BCVA was 0.6 (0.4-1). Post-AGV, median intraocular pressure as measured by scleral Schiotz reduced significantly from 30.4 (20.6-30.4) to 13.5(12.2-14.8) mm Hg (P < 0.0001), and the mean number of antiglaucoma medications significantly decreased from 3.4 to 1.7 (P < 0.0001). Mean BCVA (P = 0.24) remained stable. Humphrey visual fields mean deviation progressed from -13.5 dB (-25, -9) to -26 dB (-30, -13) at final follow-up (P = 0.05) and progression occurred in 10 eyes. Seven eyes (18.4%) had postoperative complications needing surgical intervention, including tube block [5 eyes (13.1%)] and tube exposure [2 eyes (5%)]. One failed AGV needed additional glaucoma surgery after 8 years. None had implant extrusion/explanation or endophthalmitis.

Conclusions: Ahmed glaucoma valve implantation offered promising results in managing glaucoma in eyes with type 1 KPro, particularly in relatively young Indian population. However, close monitoring for tube-related complications and glaucoma progression is warranted.

{"title":"Intermediate-Term Outcomes and Complications of Ahmed Glaucoma Valve in Type 1 Keratoprostheses.","authors":"Gowri Pratinya Kolipaka, Ramyashri Sastry, Naveen Nukala, Swapna S Shanbhag, Sirisha Senthil","doi":"10.1097/ICO.0000000000003819","DOIUrl":"https://doi.org/10.1097/ICO.0000000000003819","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate intermediate-term outcomes and complications associated with Ahmed glaucoma valve (AGV) implantation in eyes with type 1 keratoprosthesis (KPro).</p><p><strong>Methods: </strong>We retrospectively reviewed records of 43 eyes of 43 Indian patients with type 1 KPro and AGV from 2009 to 2021 with a minimum of 6-months of follow-up. Five eyes that had AGV before KPro were excluded, leaving 38 eyes for analysis. Primary outcome measure was postoperative complications. Secondary outcome measure was stability of glaucoma, assessed by Humphrey visual fields, intraocular pressure, and best-corrected visual acuity (BCVA). Sight-threatening complications, implant removal, or repeat glaucoma surgery was considered failure.</p><p><strong>Results: </strong>Median age (interquartile range) at AGV implantation was 36.5 (23-49) years, with median post-AGV follow-up of 30.5 (6.5-53) months. Preoperative logarithm of minimal angle of resolution median BCVA was 0.6 (0.4-1). Post-AGV, median intraocular pressure as measured by scleral Schiotz reduced significantly from 30.4 (20.6-30.4) to 13.5(12.2-14.8) mm Hg (P < 0.0001), and the mean number of antiglaucoma medications significantly decreased from 3.4 to 1.7 (P < 0.0001). Mean BCVA (P = 0.24) remained stable. Humphrey visual fields mean deviation progressed from -13.5 dB (-25, -9) to -26 dB (-30, -13) at final follow-up (P = 0.05) and progression occurred in 10 eyes. Seven eyes (18.4%) had postoperative complications needing surgical intervention, including tube block [5 eyes (13.1%)] and tube exposure [2 eyes (5%)]. One failed AGV needed additional glaucoma surgery after 8 years. None had implant extrusion/explanation or endophthalmitis.</p><p><strong>Conclusions: </strong>Ahmed glaucoma valve implantation offered promising results in managing glaucoma in eyes with type 1 KPro, particularly in relatively young Indian population. However, close monitoring for tube-related complications and glaucoma progression is warranted.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143064239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cornea
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1